Related Experiment Videos
Changes in endothelin-1, 6-keto-PG-F1 alpha, and TX-B2 in random pattern flaps
1Department of Plastic and Reconstructive Surgery, St. Marianna University School of Medicine, Kawasaki, Japan.
Journal of Cardiovascular Pharmacology
|May 22, 1998
Summary
Endothelin-1 (ET-1) levels change dynamically in random flaps after surgery. Blocking ET-1 receptors with FR-139317 improved flap survival, suggesting ET-1 impacts microcirculation.
Area of Science:
- Vascular Surgery
- Wound Healing
- Tissue Engineering
Background:
- Microcirculation is crucial for flap survival.
- Endothelin-1 (ET-1) and eicosanoids are key regulators of vascular tone.
- Understanding their kinetic changes in flaps is vital for improving surgical outcomes.
Purpose of the Study:
- To investigate the kinetic changes in the ratio of endothelin-1 (ET-1) and eicosanoids in random pattern flaps.
- To determine the role of ET-1 in flap microcirculation and survival.
- To evaluate the effect of an ETA receptor antagonist on flap survival.
Main Methods:
- Measurement of ET-1 and eicosanoid (6-keto-PGF1α, TXB2) levels in different regions of rat random pattern flaps at 0 and 6 hours post-surgery.
- Administration of an ETA receptor antagonist (FR-139317) to assess its impact on flap survival.
- Analysis of ET-1 and eicosanoid distribution and kinetic changes within the flap.
Main Results:
- ET-1 levels decreased in peripheral flap regions but increased significantly in the flap base region 6 hours post-surgery.
- Eicosanoid ratios were significantly lower in all regions 6 hours post-surgery compared to immediately after surgery.
- The ETA receptor antagonist FR-139317 significantly extended flap survival.
- A differential distribution of ET-1 and eicosanoids was observed within the flap.
Conclusions:
- ET-1 plays a significant role in regulating microcirculation within random pattern flaps.
- ET-1's localized increase at the flap base may contribute to altered blood flow.
- Targeting ET-1 signaling with antagonists like FR-139317 holds therapeutic potential for improving flap survival in reconstructive surgery.